Search is currently unavailable
U.S. Investment Grade Credit Index Fund

U.S. Investment Grade Credit Index Fund - Institutional Plus EUR Acc (VANEIPE)

About this fund

Fund objectives

  • The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the Bloomberg Global Aggregate USD Credit Float Adjusted Bond Index (the “Index”).
  • The Index is a market-weighted index of U.S. dollar-denominated Investment grade fixed-income securities with maturities greater than one year and a minimum issue size of USD 300 million, but excluding certain sectors as set out below. The Index includes securities issued by global corporates, securitised, and government-related/supranational entities, but excludes U.S. Treasuries and certain securitised sectors and issues as defined by the Index provider.
  • The Fund attempts to: 1. Track the performance of the Index by investing through physical acquisition in a portfolio of securities that, insofar as possible and practicable, consists of a representative sample of the component securities of the Index. 2. Remain fully invested except in extraordinary market, political or similar conditions where the Fund may temporarily depart from this investment policy to avoid losses.

Fund facts

Share class inception
19 Dec 2013
Minimum initial investment
€100,000,000.00
Investment structure
Irish UCITS
Share Class Assets'
Total Assets
Risk indicator
Strategy
Index
Asset Class
Bond
Domicile
Ireland
Dividend schedule
—
Currency
EUR
Index ticker
I23047EU
Benchmark
Bloomberg Global Aggregate USD Credit Float Adjusted Bond Index
Register countries
Ireland, Norway, Switzerland, France, Luxembourg, Sweden, Finland, Denmark, Liechtenstein, Portugal, Iceland, Germany, Austria, Italy, Spain, Netherlands and United Kingdom

The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

Performance

Risk and Volatility

As at 30 Sep 2026

Beta
R²
Annualized Tracking Error
1 year
3 years
5 years

Portfolio data

Characteristics
FundamentalsFundBenchmarkAs at
Number of bonds 7,157 14,378 30 Sep 2026
6.0% 6.0% 30 Sep 2026
4.7% 4.6% 30 Sep 2026
9.1 Years 9.1 Years 30 Sep 2026
A A 30 Sep 2026
5.8 Years 5.8 Years 30 Sep 2026
Cash Investment 0.0% — 30 Sep 2026
Market allocation

As at 30 Sep 2026

CountryRegionFundBenchmarkVariance +/-
United States of AmericaNorth America 63.88% 62.98% 0.90%
SupranationalOther 3.95% 4.10% -0.15%
CanadaNorth America 3.54% 3.67% -0.13%
United KingdomEurope 3.00% 3.32% -0.32%
JapanPacific 2.29% 2.35% -0.06%
Saudi ArabiaEmerging Markets 2.03% 2.01% 0.02%
GermanyEurope 2.02% 2.04% -0.02%
FranceEurope 2.00% 1.83% 0.17%
MexicoEmerging Markets 1.39% 1.37% 0.02%
AustraliaPacific 1.34% 1.49% -0.15%
United Arab EmiratesEmerging Markets 1.25% 1.22% 0.03%
ChinaEmerging Markets 1.20% 1.39% -0.19%
South KoreaPacific 1.07% 1.03% 0.04%
IndonesiaEmerging Markets 0.89% 0.87% 0.02%
ItalyEurope 0.64% 0.56% 0.08%
Distribution by credit quality (% of funds)

As at 30 Sep 2026

Bar chart showing the credit quality breakdown for the fund and its benchmark. The same data is available in the table view.
Distribution by credit issuer (% of funds)

As at 30 Sep 2026

Bar chart showing the credit issuer breakdown for the fund and its benchmark. The same data is available in the table view.
Distribution by credit maturity (% of funds)

As at 30 Sep 2026

Bar chart showing the credit maturity breakdown for the fund and its benchmark. The same data is available in the table view.
Holdings details

As at 30 Sep 2026

Holding name% of market valueMarket valueFace amountCoupon/YieldMaturity date
Goldman Sachs Group Inc/The 0.16245% €2,300,747.78 2,400,000 4.97% 03 Jun 2032
United States Treasury Note/Bond 0.14371% €2,035,218.75 2,040,000 4.75% 30 Sep 2028
United States Treasury Note/Bond 0.13187% €1,867,640.63 2,052,000 5.00% 15 May 2056
Eagle Funding Luxco Sarl 0.11998% €1,699,272.76 1,725,000 5.50% 17 Aug 2030
CVS Health Corp 0.10598% €1,500,945.77 1,523,000 4.30% 25 Mar 2028
Sopaipilla Investor LLC 0.10501% €1,487,208.78 1,500,000 7.53% 30 Nov 2048
UnitedHealth Group Inc 0.10255% €1,452,330.22 1,475,000 4.70% 15 Apr 2029
Barclays PLC 0.09917% €1,404,507.10 1,375,000 7.39% 02 Nov 2028
BNP Paribas SA 0.09667% €1,369,117.61 1,400,000 4.38% 01 Mar 2033
Wells Fargo & Co 0.09200% €1,302,998.46 1,358,000 4.84% 20 May 2032

Prices and distribution

Prices

NAV Price (EUR)
€176.65
EUR
Change
-€0.60-0.34%
At closure 09 Nov 2026
NAV 52-week high
€177.25
At closure 10 Nov 2026
NAV 52-week low
€166.38
At closure 10 Nov 2026
NAV 52-week difference
€10.88
Change
+6.14%
At closure 10 Nov 2026
Historical Prices

-

Inception date

19 Dec 2013

Date NAV (EUR)
09 Nov 2026 €176.6545
06 Nov 2026 €177.2544
05 Nov 2026 €176.1407
04 Nov 2026 €175.7422
03 Nov 2026 €175.4708
02 Nov 2026 €175.8012
30 Oct 2026 €176.2973
29 Oct 2026 €175.9896
28 Oct 2026 €176.0067
27 Oct 2026 €176.1462

Purchase information

Currency

Base currency:EUR

Fund codes

  • Bloomberg:VANEIPE
  • Citi:JWGS
  • ISIN:IE00BFPMB139
  • MEX ID:VIAABR
  • SEDOL:BFPMB13